Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Lidocaine for Brachial Plexus Block
NCT01969903Phase 2Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Nov 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of dexmedetomidine in pain (3 arms), sponsored by NYU Langone Health. Primary endpoint: Pain scores on Visual Analog Scale. Planned start Nov 2014; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01969903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01969903.